Deutsche Bank
GLUE icon

Deutsche Bank’s Monte Rosa Therapeutics GLUE Stock Holding History

Deutsche Bank’s Portfolio GLUE Stock Details GLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.82M Buy
75,061
+27,199
+57% +$514K ﹤0.01% 1963
2026
Q1 		$787K Buy
47,862
+14,754
+45% +$282K ﹤0.01% 2324
2025
Q4 		$519K Buy
33,108
+8,537
+35% +$115K ﹤0.01% 2546
2025
Q3 		$182K Buy
24,571
+5,941
+32% +$31.5K ﹤0.01% 3110
2025
Q2 		$84K Sell
18,630
-6,220
-25% -$27.7K ﹤0.01% 3312
2025
Q1 		$115K Sell
24,850
-4,214
-14% -$25.8K ﹤0.01% 3151
2024
Q4 		$202K Buy
29,064
+6,633
+30% +$49.8K ﹤0.01% 3089
2024
Q3 		$119K Buy
22,431
+11,571
+107% +$58.4K ﹤0.01% 3155
2024
Q2 		$40.6K Sell
10,860
-2,528
-19% -$12.9K ﹤0.01% 3359
2024
Q1 		$94.4K Sell
13,388
-571
-4% -$3.39K ﹤0.01% 3195
2023
Q4 		$78.9K Hold
13,959
– – ﹤0.01% 3325
2023
Q3 		$66.9K Hold
13,959
– – ﹤0.01% 3335
2023
Q2 		$95.6K Sell
13,959
-12,319
-47% -$79.7K ﹤0.01% 3294
2023
Q1 		$205K Buy
26,278
+305
+1% +$2.12K ﹤0.01% 2988
2022
Q4 		$198K Buy
25,973
+2,481
+11% +$20.7K ﹤0.01% 2984
2022
Q3 		$192K Buy
23,492
+10,026
+74% +$92.1K ﹤0.01% 2970
2022
Q2 		$130K Sell
13,466
-2,584
-16% -$26K ﹤0.01% 3387
2022
Q1 		$225K Buy
16,050
+9,040
+129% +$126K ﹤0.01% 3198
2021
Q4 		$143K Sell
7,010
-688
-9% -$14.4K ﹤0.01% 3536
2021
Q3 		$171K Buy
+7,698
New +$221K ﹤0.01% 3647

Other funds holding GLUE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deutsche Bank's GLUE Position: Q2 2026 in Review

Deutsche Bank increased its Monte Rosa Therapeutics (GLUE) stake by 57% in Q2 2026, buying an estimated $514K and bringing the position to 75,061 shares worth $1.82M. The position accounts for ﹤0.01% of the portfolio, ranked #1963.

Deutsche Bank first reported a position in GLUE in Q3 2021 and has held it in 20 quarters since. 192 funds tracked by Wall St. Rank hold GLUE as of Q2 2026.

  • Deutsche Bank held 75,061 shares of Monte Rosa Therapeutics worth $1.82M as of Q2 2026.
  • Deutsche Bank bought 27,199 Monte Rosa Therapeutics shares in Q2 2026, an estimated $514K.
  • Monte Rosa Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #1963 holding.
  • Deutsche Bank first reported a position in Monte Rosa Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • 192 funds tracked by Wall St. Rank held Monte Rosa Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.